P-45
In vitro leishmanicidal activity of Artennua®
Poster P-45
Jessica Martín, Jacob Lorenzo-Morales, José E. Piñero, Luis Matías-Hernández
P-44
Laboratory assessment of treatment with artemisin against canine leishmaniosis: a case report
P-43
Maité Sillon, Terence Pellet, Laure Poincelot, Jean-Baptiste Rascle
Poster P-43
Magali Dolon, Terence Pellet, Isabelle Eynard, Paul Schreiber, Laure Poincelot, Jean-Baptiste Rascle
P-42
Miltefosine assay in plasma, urine and faeces of dogs treated with an oral suspension containing miltefosine 2%
P-41
In vitro human skin absorption of a commercial veterinary drug containing Miltefosine 2%
P-40
Reduction of anti-Leishmania antibody levels and outcome in a domestic ferret (Mustela putorius furo) with renal disease treated with a miltefosine plus allopurinol combined therapeutic protocol
Poster P-40
Jacobo Giner, Diego López-Sahuquillo, Álex Gómez, Diana Marteles, Maite Verde, Antonio Fernández, Sergio Villanueva-Saz
P-39
A PCR prevalence study of vector-borne pathogens of cats in Greece - the major challenges
P-37
Coinfections of Leishmania infantum and other zoonotic pathogens in apparently healthy Cirneco dell’Etna dogs’ breed. Screening of hematological traits
Poster P-37
Lola Llobat, Annalisa Amato, Mario Tomasello, Carmelo Cavallo, Viviana Floridia, Cristina Tomasella, Luigi Liotta2
P-36
Interleukin 27 regulates adaptative immune responses associated with control of parasite replication in Canine Leismaniosis
Poster P-36
Valéria M. F. de Lima, Marilene O. Santos, Gabriela T. Rebech, Jaqueline P. Bragato, Matheus F. Soares, Sidnei F. Costa, Flávia R. Eugênio, Paulo S. P. dos Santos
P-35
Leishmania tarentolae infecting dog macrophages exert s a protective effect against Leishmania infantum by modulating cytokines expression
Poster P-35
Viviane Noll Louzada Flores, Maria Stefania Latrofa, Jairo Alfonso Mendoza Roldan, Sara Epis, Ilaria Varotto Boccazzi, Claudio Bandi , Domenico Otranto